High egg consumption is associated with increased cardiovascular disease risk in a dose-response manner.
7 events · 3 assessments · 3 decisions
Reassessed (status unchanged)
Subclaim_change trigger: the diabetic-concentration subclaim moved supported→contested (Drouin-Chartier 2020/2021 US pooling finds no CHD association even in prevalent T2D; diet-quality confounding leading explanation; older subgroup meta-analyses still affirm). Assessed materiality as low. That subclaim is one scope-restriction leg of the 'against' argument; weakening it makes the field murkier but supplies no graded monotonic association, which is the parent's least-supported component. Parent remains contested (confidence 0.85, credence 0.33) — the verdict rested on the threshold/subgroup-vs-gradient distinction, which is intact. Refreshed both reader-facing assessment and reasoning trace to reflect the eroding diabetic-subgroup explanation. Structure unchanged (no missing dependency; do not re-decompose). Importance left at 0.45: a well-known but moderately consequential nutrition debate, single local dependent (itself a subclaim). No dependent notification: parent status did not change, so no material propagation.
Reassessed: still Contested
verdict confidence 0.85 · credence 0.33
Reassessed (status unchanged: contested)
Triggered by subclaim a4173db8 (regional US-positive / Europe-Asia-null pattern) moving from supported to contested, since the two leading meta-analyses (BMJ 2020 incidence vs Circulation 2022 mortality) disagree on the specific regional shape. Judged materiality as low for the parent's status: the specific regional characterization weakens, but regional heterogeneity and the absence of a clean universal positive dose-response remain intact, so the change is absorbed rather than flipping the parent. If anything the meta-analytic disagreement reinforces the contested verdict. Confirmed the current evidentiary spread with a web search (Godos 2020 inverse at moderate intake; Drouin-Chartier/BMJ 2020 null RR≈0.98; positive signals only at high intake or in diabetic subgroups), which supports keeping status=contested. Refined the reader-facing assessment and reasoning trace to soften the now-disputed 'US positive / Europe & Asia null' summary and to foreground that the dose-response (monotonic gradient) component is the weakest part of the claim. Kept confidence 0.85 and set credence 0.33. Left importance at 0.45 (a live public-nutrition debate but niche in global claimspace). No structural changes: did not re-decompose; existing subclaims and arguments remain apt. Only local dependent is one of the claim's own subclaims (4408df03), and parent status did not change, so no dependent notification warranted.
Reassessed: still Contested
verdict confidence 0.85 · credence 0.33
Structured and assessed
First pass. Decomposed into two lines of reasoning using existing graph claims (no new nodes needed, reflecting a mature neighborhood). FOR: pooled-cohort dose-response for dietary cholesterol plus the eggs-raise-LDL / LDL-causes-CVD mechanistic chain. AGAINST: null association in healthy adults, US-vs-Europe/Asia heterogeneity, concentration among diabetics, and a threshold (risk at high but not moderate intake) rather than monotonic gradient. Set importance to 0.45 (contested, publicly relevant but a narrow dose-response framing). Assessed CONTESTED, confidence 0.85, credence 0.35: credible evidence on both sides, but the specific dose-response framing is the weaker component; a universal monotonic gradient is not well established, a subgroup/context-dependent association is more defensible. Search budget for external verification was exhausted this run, but the graph's neighboring claims (independently assessed contested/supported) and established literature strongly corroborate the contested reading.
Assessed Contested
verdict confidence 0.85 · credence 0.35
Whether high egg consumption is associated with cardiovascular disease in a graded, dose-response manner remains genuinely unsettled, and the evidence divides along recognizable lines. Some large pooled analyses of United States cohorts report that each additional increment of egg or dietary cholesterol intake tracks with modestly higher cardiovascular risk, consistent with a dose-response pattern, and a plausible mechanism supports this: eggs raise LDL cholesterol, and elevated LDL causes cardiovascular disease. Against a general dose-response stand several strong observations. Large meta-analyses and cohorts find no significant association in healthy adults, and the positive signal is not universal: it appears in US populations but is null or even inverse in European and Asian cohorts, and is concentrated among people with diabetes. Where an association does emerge, it tends to appear at high intake rather than rising smoothly from moderate intake, pointing to a threshold rather than a clean monotonic gradient. The disagreement is largely empirical and turns on residual confounding (egg intake correlates with other dietary and lifestyle risk factors), population and dietary-context differences, and how intake is modeled. It would be narrowed by better-adjusted analyses that separate eggs from accompanying foods and by consistent findings across diverse populations. As stated, a universal dose-response association is weakly supported at best; a subgroup- and context-dependent association is the more defensible reading.
Claim entered the graph